A clinical/immunological neuromyelitis optica association study
<p>Neuromyelitis optica (NMO) and NMO spectrum disorders (NMOSD) are associated with the disease-specific autoantibody aquaporin-4 (AQP4-Ab), which is thought to be pathogenic. Some NMO/NMOSD patients do not have this antibody and may have different clinical and immuno-pathological disease ch...
Main Authors: | Kitley, J, Joanna Louise Kitley |
---|---|
Other Authors: | Palace, J |
Format: | Thesis |
Language: | English |
Published: |
2014
|
Subjects: |
Similar Items
-
Use of mitoxantrone in neuromyelitis optica.
by: Kitley, J, et al.
Published: (2011) -
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
by: Kitley, J, et al.
Published: (2014) -
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
by: Kitley, J, et al.
Published: (2014) -
Novel imaging biomarkers for the diagnosis and study of Neuromyelitis optica
by: Matthews, LAE
Published: (2013) -
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
by: Kitley, J, et al.
Published: (2014)